(Bloomberg) — Eli Lilly & Co. permitted a program to repurchase as much as $15 billion of its personal inventory amid speedy progress fueled partially by blockbuster weight-loss drug Zepbound.
Most learn on Bloomberg
The corporate additionally elevated its quarterly dividend by 15%, in keeping with a press release launched Monday. Shares rose 1.3% in late buying and selling after U.S. markets closed.
Share repurchases could also be made every now and then on the discretion of administration, Lilly mentioned.
Most learn from Bloomberg Businessweek
©2024 Bloomberg LP
#Lilly #approves #billion #inventory #buybacks #will increase #dividend , #Gossip247
,
